p53 mutations in nonmelanoma skin cancer of the head and neck: molecular evidence for field cancerization.

Multiple and distinct p53 mutations were detected by DNA sequence analysis in tumor and adjacent nonmalignant skin samples from eight patients with nonmelanoma skin cancer of the head and neck, providing unambiguous evidence for field cancerization. The mutations consisted of C-->T transitions at dipyrimidine sequences (30% of all single base substitutions), T-->C transitions (47%), and G-->T transversions (12%), suggesting that other carcinogens may act along with UV radiation in the development of nonmelanoma skin cancer. Patient interviews revealed that, in addition to substantial exposure to solar UV radiation, most had a history of smoking and were exposed to carcinogens from industrial or agricultural sources. These data show that extensive molecular epidemiological investigations are necessary to elucidate risk factors associated with the disease in localities where patients often report substantial exposure to environmental carcinogens.

[1]  L. Loeb,et al.  Nickel induces a signature mutation for oxygen free radical damage. , 1993, Cancer research.

[2]  T. Jacks,et al.  Sunburn and p53 in the onset of skin cancer , 1994, Nature.

[3]  F. Urbach.  Incidence of nonmelanoma skin cancer in the United States , 1984 .

[4]  R. Carroll,et al.  Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. , 1989, The Journal of dermatologic surgery and oncology.

[5]  Y. Kubo,et al.  p53 gene mutations in human skin cancers and precancerous lesions: comparison with immunohistochemical analysis. , 1994, The Journal of investigative dermatology.

[6]  K. Mullis,et al.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase. , 1988, Science.

[7]  A. Gronenborn,et al.  High-resolution structure of the oligomerization domain of p53 by multidimensional NMR. , 1994, Science.

[8]  T. Sekiya,et al.  Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. , 1989, Genomics.

[9]  P. Jeffrey,et al.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. , 1994, Science.

[10]  B. Shaw,et al.  Bisulfite induces tandem double CC-->TT mutations in double-stranded DNA. 2. Kinetics of cytosine deamination. , 1994, Biochemistry.

[11]  R. Weber,et al.  Advanced basal and squamous cell carcinomas of the skin of the head and neck. , 1990, Cancer treatment and research.

[12]  R. Mirimanoff,et al.  Clinical implications of the p53 tumor-suppressor gene. , 1994, The New England journal of medicine.

[13]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[14]  F. Mitelman,et al.  Cytogenetic analysis of 33 basal cell carcinomas. , 1991, Cancer research.

[15]  Risk of Subsequent Basal Cell Carcinoma and Squamous Cell Carcinoma of the Skin Among Patients With Prior Skin Cancer , 1992 .

[16]  A. Ziegler,et al.  Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. Simon,et al.  A role for sunlight in skin cancer: UV-induced p53 mutations in squamous cell carcinoma. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[18]  N. Basset-Seguin,et al.  p53 gene mutations in human epithelial skin cancers. , 1993, Oncogene.

[19]  B. Hanusa,et al.  New primary nonmelanoma skin cancer in patients with a history of squamous cell carcinoma of the skin. Implications and recommendations for follow-up. , 1992, Journal of the American Academy of Dermatology.

[20]  C. Campbell,et al.  p53 mutations are common and early events that precede tumor invasion in squamous cell neoplasia of the skin. , 1993, The Journal of investigative dermatology.

[21]  C. Harris,et al.  Geographic variation of p53 mutational profile in nonmalignant human liver. , 1994, Science.

[22]  T. Mikkelsen,et al.  Clonal expansion of p53 mutant cells is associated with brain tumour progression , 1992, Nature.

[23]  T. Yagi,et al.  Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients. , 1993, Cancer research.

[24]  N. Swanson,et al.  Squamous cell carcinoma of the skin (excluding lip and oral mucosa). , 1992, Journal of the American Academy of Dermatology.

[25]  佐藤 まゆみ.  Ultraviolet-specific mutations in p53 gene in skin tumors in xeroderma pigmentosum patients , 1994 .

[26]  A. H. Wanamarta,et al.  C/G to A/T transversions represent the main type of mutation induced by gamma-irradiation in double-stranded M13mp10 DNA in a nitrogen-saturated solution. , 1993, Mutation research.

[27]  D. Schaid,et al.  Novel pattern of p53 gene mutations in an American black cohort with high mortality from breast cancer , 1994, The Lancet.

[28]  D. Slaughter,et al.  “Field cancerization” in oral stratified squamous epithelium. Clinical implications of multicentric origin , 1953, Cancer.

[29]  J. Robinson.  What are adequate treatment and follow-up care for nonmelanoma cutaneous cancer? , 1987, Archives of dermatology.

[30]  W. Pierceall,et al.  Mutations in the p53 tumor suppressor gene in human cutaneous squamous cell carcinomas , 1991, Molecular carcinogenesis.

[31]  J. Rees,et al.  Genetic alterations in non-melanoma skin cancer. , 1994, The Journal of investigative dermatology.

[32]  S. H. Fox,et al.  The risk of developing subsequent nonmelanoma skin cancers. , 1990, Journal of the American Academy of Dermatology.

[33]  Yao-Tseng Chen,et al.  Frameshift and nonsense p53 mutations in squamous-cell carcinoma of head and neck - non-reactivity with 3 anti-p53 monoclonal-antibodies. , 1994, International journal of oncology.

[34]  W. Pierceall,et al.  High frequency of p53 mutations in ultraviolet radiation-induced murine skin tumors: evidence for strand bias and tumor heterogeneity. , 1993, Cancer research.

[35]  G. Coetzee,et al.  5-Methylcytosine as an endogenous mutagen in the human LDL receptor and p53 genes. , 1990, Science.

[36]  F. Scinicariello,et al.  p53 mutations in basal cell carcinomas. , 1992, Cancer research.

[37]  C. Perez.  Nonmelanoma cancers of the skin. , 1993, The New England journal of medicine.

[38]  D. Alberts,et al.  Analysis of the p53 gene in human precancerous actinic keratosis lesions and squamous cell cancers. , 1994, Cancer letters.

[39]  B. Vogelstein,et al.  p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. , 1990, Cancer research.

[40]  D. English,et al.  UV and skin cancer: specific p53 gene mutation in normal skin as a biologically relevant exposure measurement. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[41]  C. Sutter,et al.  Carcinogen-specific mutational pattern in the p53 gene in ultraviolet B radiation-induced squamous cell carcinomas of mouse skin. , 1992, Cancer research.

[42]  W. Hong,et al.  Discordant p53 gene mutations in primary head and neck cancers and corresponding second primary cancers of the upper aerodigestive tract. , 1993, Cancer research.